Compound Detail
CHEMBL5596711
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5596711 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | PQAVZUPPSMHRKB-SSDMNJCBSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
418.5
MW (Da)
4.74
ALogP
5
HBA
2
HBD
61.3
PSA (Ų)
0.75
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.42
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 7.42 | 7.42 | 38.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 38.0 | nM | 7.42 | Inhibition of IL-1beta release in PMA-differentiated/ LPS and nigericin stimulat... | 39169676 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 39169676 | 10.1021/acs.jmedchem.4c01341 | Unchecked | 3 |
Data from ChEMBL 36 via Core Engine